Table 1 Clinical characteristics of the cardiac myxoma patients (n = 23)
General information | N (%) |
|---|---|
Gender (male / female) | 8(34.78%)/ 15(65.22%) |
Age, years (mean ± SD) | 2.42–12.75 (8.92 ± 3.97) |
Weight (kg) | 11- 45 (28.21 ± 13.42) |
Location: | |
Left atrium Right atrium Right ventricle | 15 (65.22%) 7(30.43%) 1 (4.35%) |
NYHA class: | |
NYHA II NYHA III NYHA IV | 9 (39.13%) 12(52.17%) 2 (8.70%) |
Clinical manifestations: | |
Asymptomatic | 1 (4.35%) |
Cough, shortness of breath, and palpitations | 9 (39.13%) |
Weakness in upper and lower limbs with aphasia | 2 (8.70%) |
Dizziness and fainting | 3 (13.04%) |
Decrease in exercise tolerance | 6 (26.09%) |
Superior vena cava obstruction syndrome | 1 (4.35%) |
Cerebral infarction with hemiplegia | 1 (4.35%) |
The duration of symptoms: | |
Within 1 week January to March March to June June to 1 year Over 1 year | 8(34.78%) 2(8.70%) 6(26.09%) 4(17.39%) 3(13.04%) |
Physical examination: | |
simple diastolic murmurs | 18(78.26%) |
simple systolic murmurs | 5(21.74%) |
Electrocardiogram: | |
Sinus tachycardia | 7(30.43%) |
Atrial fifibrillation | 9(39.13%) |
Abnormal P wave | 2(8.70%) |
T wave change | 1(4.35%) |
Normal | 4 (17.39%) |
The site of origin of the CM: | |
Interatrial septum | 10 (43.48%) |
Lateral atrial wall | 6 (26.09%) |
Right superior pulmonary vein | 2 (8.70%) |
Mitral valve | 3 (13.04%) |
Tricuspid valve | 1(4.35%) |
Right ventricle | 1(4.35%) |
The tumor size (Shortest diameter×longest diameter): | |
< 2 × 3 cm | 6(26.09%) |
2 × 3 cm-3 × 5 cm | 8(34.78%) |
3 × 5 cm-5 × 7 cm | 7(30.43%) |
> 7 × 8 cm | 2(8.70%) |